Bile Acid Sequestrants for Lipid and Glucose Control
Open Access
- 22 January 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Current Diabetes Reports
- Vol. 10 (1), 70-77
- https://doi.org/10.1007/s11892-009-0087-5
Abstract
Bile acids are generated in the liver and are traditionally recognized for their regulatory role in multiple metabolic processes including bile acid homeostasis, nutrient absorption, and cholesterol homeostasis. Recently, bile acids emerged as signaling molecules that, as ligands for the bile acid receptors farnesoid X receptor (FXR) and TGR5, activate and integrate multiple complex signaling pathways involved in lipid and glucose metabolism. Bile acid sequestrants are pharmacologic molecules that bind to bile acids in the intestine resulting in the interruption of bile acid homeostasis and, consequently, reduction in low-density lipoprotein cholesterol levels in hypercholesterolemia. Bile acid sequestrants also reduce glucose levels and improve glycemic control in persons with type 2 diabetes mellitus (T2DM). This article examines the mechanisms by which bile acid–mediated activation of FXR and TGR5 signaling pathways regulate lipid and glucose metabolism and the potential implications for bile acid sequestrant–mediated regulation of lipid and glucose levels in T2DM.Keywords
This publication has 54 references indexed in Scilit:
- TGR5-Mediated Bile Acid Sensing Controls Glucose HomeostasisCell Metabolism, 2009
- Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR−/− and apoE−/− miceJournal of Lipid Research, 2009
- Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid SynthesisPublished by Elsevier BV ,2009
- Bile acids and signal transduction: Role in glucose homeostasisCellular Signalling, 2008
- Colesevelam Hydrochloride Therapy in Patients With Type 2 Diabetes Mellitus Treated With MetforminArchives of Internal Medicine, 2008
- Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based TherapyDiabetes Care, 2008
- Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaeaBiochemical and Biophysical Research Communications, 2007
- Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1Biochemical and Biophysical Research Communications, 2005
- The Enzymes, Regulation, and Genetics of Bile Acid SynthesisAnnual Review of Biochemistry, 2003
- Identification of membrane-type receptor for bile acids (M-BAR)Biochemical and Biophysical Research Communications, 2002